文献速递颈动脉与弓上血管

控制与未控制高血压对颈动脉血运重建术结局的影响

The effect of controlled vs uncontrolled hypertension on outcomes of carotid revascularization procedures.
PubMed 文献 · J Vasc Surg · 2024-05-18

基于血管质量倡议(VQI)2020年4月至2022年6月数据,纳入34653例颈动脉内膜剥脱术(CEA)、8199例经股动脉颈动脉支架置入术(TFCAS)和17309例经颈动脉血运重建术(TCAR)患者。未控制高血压(uHTN)与CEA、TFCAS和TCAR术后院内卒中/死亡/心肌梗死复合风险升高及住院时间延长相关。在uHTN患者中,TFCAS的卒中、院内死亡、再灌注综合征和住院时间延长风险高于CEA,而TCAR与CEA结局无统计学显著差异。

要点

  • 未控制高血压与CEA、TFCAS和TCAR术后院内卒中/死亡/心肌梗死复合风险升高相关。
  • 未控制高血压患者中,TFCAS的卒中、院内死亡、再灌注综合征和住院时间延长风险高于CEA。
  • 未控制高血压患者中,TCAR与CEA的结局无统计学显著差异。

核心结论

  • 与高血压控制患者相比,未控制高血压患者颈动脉血运重建术后卒中和死亡风险更高。
  • 在未控制高血压患者中,TFCAS结局最差,CEA和TCAR是更安全的干预措施。
  • 未控制高血压合并症状性颈动脉疾病患者中,CEA或TCAR治疗的结局优于TFCAS。

研究设计与样本

  • 使用血管质量倡议(VQI)数据,回顾性分析2020年4月至2022年6月接受CEA、TFCAS或TCAR的患者。
  • 共纳入34653例CEA(uHTN 11347例,32.7%)、8199例TFCAS(uHTN 2307例,28.1%)和17309例TCAR(uHTN 4990例,28.8%)患者。
  • 按高血压控制状态分为两组:控制高血压(cHTN)组为接受药物治疗且血压<130/80 mm Hg,未控制高血压(uHTN)组为血压≥130/80 mm Hg。
  • 采用logistic回归模型进行多因素分析。

主要发现

  • 与cHTN相比,uHTN与CEA术后院内卒中/死亡/心肌梗死复合风险升高相关(aOR 1.56;95%CI 1.30-1.87;P<.001)。
  • 与cHTN相比,uHTN与TFCAS术后院内卒中/死亡/心肌梗死复合风险升高相关(aOR 1.59;95%CI 1.21-2.08;P<.001)。
  • 与cHTN相比,uHTN与TCAR术后院内卒中/死亡/心肌梗死复合风险升高相关(aOR 1.39;95%CI 1.12-1.73;P=.003)。
  • uHTN与所有颈动脉血运重建方法术后住院时间延长相关。
  • 在uHTN患者中,与CEA相比,TFCAS与卒中风险升高(aOR 1.82;95%CI 1.39-2.37;P<.001)、院内死亡风险升高(aOR 3.73;95%CI 2.25-6.19;P<.001)、再灌注综合征风险升高(aOR 6.24;95%CI 3.57-10.93;P<.001)和住院时间延长风险升高(aOR 1.87;95%CI 1.51-2.32;P<.001)相关。

关键数值与推荐

  • 控制高血压定义为接受药物治疗且血压<130/80 mm Hg。
  • 未控制高血压定义为血压≥130/80 mm Hg。
  • 主要结局为院内卒中、死亡、心肌梗死和30天死亡率。
  • 次要结局为术后低血压或高血压、再灌注综合征、住院时间延长(>1天)、卒中/死亡和卒中/死亡/心肌梗死。

临床怎么用

  • 作者认为,择期颈动脉血运重建术前应治疗高血压。
  • 作者认为,在未控制高血压患者中,CEA和TCAR是更安全的干预措施。
  • 作者认为,未控制高血压合并症状性颈动脉疾病患者采用CEA或TCAR的结局优于TFCAS。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypertension (HTN) has been implicated as a strong predictive factor for poorer outcomes in patients undergoing various vascular procedures. However, limited research is available that examines the effect of uncontrolled HTN (uHTN) on outcomes after carotid revascularization. We aimed to determine which carotid revascularization procedure yields the best outcome in this patient population. METHODS: We studied patients undergoing carotid endarterectomy (CEA), transfemoral carotid artery stenting (TFCAS), or transcarotid artery revascularization (TCAR) from April 2020 to June 2022 using data from the Vascular Quality Initiative. Patients were stratified into two groups: those with cHTN and those with uHTN. Patients with cHTN were those with HTN treated with medication and a blood pressure of <130/80 mm Hg. Patients with uHTN had a blood pressure of ≥130/80 mm Hg. Our primary outcomes were in-hospital stroke, death, myocardial infarction (MI), and 30-day mortality. Our secondary outcomes were postoperative hypotension or HTN, reperfusion syndrome, prolonged length of stay (LOS) (>1 day), stroke/death, and stroke/death/MI. We used logistic regression models for the multivariate analysis. RESULTS: A total of 34,653 CEA (uHTN, 11,347 [32.7%]), 8199 TFCAS (uHTN, 2307 [28.1%]), and 17,309 TCAR (uHTN, 4990 [28.8%]) patients were included in this study. There was no significant difference in age between patients with cHTN and patients with uHTN for each carotid revascularization procedure. However, compared with patients with cHTN, patients with uHTN had significantly more comorbidities. uHTN was associated with an increased risk of combined in-hospital stroke/death/MI after CEA (adjusted odds ratio [aOR], 1.56; 95% confidence interval [CI], 1.30-1.87; P < .001), TFCAS (aOR, 1.59; 95% CI, 1.21-2.08; P < .001), and TCAR (aOR, 1.39; 95% CI, 1.12-1.73; P = .003) compared with cHTN. Additionally, uHTN was associated with a prolonged LOS after all carotid revascularization methods. For the subanalysis of patients with uHTN, TFCAS was associated with an increased risk of stroke (aOR, 1.82; 95% CI, 1.39-2.37; P < .001), in-hospital death (aOR, 3.73; 95% CI, 2.25-6.19; P < .001), reperfusion syndrome (aOR, 6.24; 95% CI, 3.57-10.93; P < .001), and extended LOS (aOR, 1.87; 95% CI, 1.51-2.32; P < .001) compared with CEA. There was no statistically significant difference between the outcomes of TCAR compared with CEA. CONCLUSIONS: The results from this study show that patients with uHTN are at a higher risk of stroke and death postoperatively compared with patients with cHTN, highlighting the importance of treating HTN before undergoing elective carotid revascularization. Additionally, in patients with uHTN, TFCAS yields the worst outcomes, whereas CEA and TCAR proved to be safer interventions. Patients with uTHN with symptomatic carotid disease treated with CEA or TCAR have better outcomes compared with those treated with TFCAS.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Farah M, Moghaddam M, Zarrintan S, et al. The effect of controlled vs uncontrolled hypertension on outcomes of carotid revascularization procedures. J Vasc Surg. 2024. PMID: 38763456. doi:10.1016/j.jvs.2024.05.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。